[{"address1": "1901 West 47th Place", "city": "Kansas City", "state": "KS", "zip": "66205", "country": "United States", "phone": "913 942 2300", "website": "https://www.cingulate.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cingulate Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company's stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults. It also focuses on developing CTx-2103 that is in a formulation stage for the treatment of anxiety. The company was founded in 2012 and is headquartered in Kansas City, Kansas.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Dr. Shane J. Schaffer Pharm.D.", "age": 49, "title": "CEO & Chairman of the Board", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 491961, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Laurie A. Myers M.B.A., Ph.D.", "age": 67, "title": "Executive VP & COO", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 415167, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Matthew N. Brams M.D.", "age": 60, "title": "Executive VP & Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 244792, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer L. Callahan CPA", "age": 53, "title": "Senior VP, CFO & Secretary", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raul R. Silva M.D.", "age": 66, "title": "Executive VP & Chief Science Officer", "yearBorn": 1958, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Thomas  Dalton", "title": "Vice President of Investor & Public Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.645, "open": 3.6544, "dayLow": 3.6306, "dayHigh": 3.94, "regularMarketPreviousClose": 3.645, "regularMarketOpen": 3.6544, "regularMarketDayLow": 3.6306, "regularMarketDayHigh": 3.94, "payoutRatio": 0.0, "beta": -0.844, "forwardPE": -0.528591, "volume": 55910, "regularMarketVolume": 55910, "averageVolume": 146420, "averageVolume10days": 68560, "averageDailyVolume10Day": 68560, "bid": 3.86, "ask": 4.72, "bidSize": 1, "askSize": 2, "marketCap": 14094559, "fiftyTwoWeekLow": 1.8, "fiftyTwoWeekHigh": 20.83, "fiftyDayAverage": 4.39, "twoHundredDayAverage": 5.15039, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1902614, "profitMargins": 0.0, "floatShares": 3203367, "sharesOutstanding": 3647660, "sharesShort": 119203, "sharesShortPriorMonth": 106850, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.037100002, "heldPercentInsiders": 0.033, "heldPercentInstitutions": 0.028239999, "shortRatio": 1.03, "shortPercentOfFloat": 0.038399998, "impliedSharesOutstanding": 3647660, "bookValue": 3.954, "priceToBook": 0.97723824, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -16348455, "trailingEps": -43.22, "forwardEps": -7.31, "lastSplitFactor": "1:12", "lastSplitDate": 1723161600, "enterpriseToEbitda": -0.122, "52WeekChange": -0.71875, "SandP52WeekChange": 0.07465422, "quoteType": "EQUITY", "currentPrice": 3.864, "targetHighPrice": 75.0, "targetLowPrice": 8.0, "targetMeanPrice": 35.4, "targetMedianPrice": 20.0, "recommendationMean": 1.75, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 10040149, "totalCashPerShare": 3.126, "ebitda": -15568522, "totalDebt": 234174, "quickRatio": 6.523, "currentRatio": 7.354, "debtToEquity": 1.945, "returnOnAssets": -1.04327, "returnOnEquity": -2.7381501, "grossProfits": -10101491, "freeCashflow": -10118891, "operatingCashflow": -16934228, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CING", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1638973800000, "regularMarketChange": 0.2190001, "regularMarketDayRange": "3.6306 - 3.94", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 146420, "fiftyTwoWeekLowChange": 2.0640001, "fiftyTwoWeekLowChangePercent": 1.1466668, "fiftyTwoWeekRange": "1.8 - 20.83", "fiftyTwoWeekHighChange": -16.966, "fiftyTwoWeekHighChangePercent": -0.8144983, "fiftyTwoWeekChangePercent": -71.875, "epsTrailingTwelveMonths": -43.22, "epsForward": -7.31, "epsCurrentYear": -9.985, "priceEpsCurrentYear": -0.3869805, "fiftyDayAverageChange": -0.5259998, "fiftyDayAverageChangePercent": -0.11981772, "twoHundredDayAverageChange": -1.2863901, "twoHundredDayAverageChangePercent": -0.24976556, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-12-08", "averageAnalystRating": "1.8 - Buy", "cryptoTradeable": false, "shortName": "Cingulate Inc.", "longName": "Cingulate Inc.", "marketState": "REGULAR", "regularMarketChangePercent": 6.008233, "regularMarketPrice": 3.864, "regularMarketTime": 1742411419, "exchange": "NCM", "messageBoardId": "finmb_1674914781", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Cingulate", "trailingPegRatio": null, "__fetch_time": "2025-03-19"}]